Correction to : Stem Cell Rev and Rep (2019) 15:690
We confirm that an unintentional human error occurred in our paper (Lee JY, Tuazon JP, Corey S, Bonsack B, Acosta S, Ehrhart J, Sanberg PR, Borlongan CV. A Gutsy Move for Cell-Based Regenerative Medicine in Parkinson's Disease: Targeting the Gut Microbiome to Sequester Inflammation and Neurotoxicity. Stem Cell Rev Rep. 2019 Oct;15(5):690-702. doi: 10.1007/s12015-019-09906-2. PMID: 31317505; PMCID: PMC6731204) contained a wrong panel in Figure 5 (panel G, Day 56, upper righthand, and labeled as TH with DAPI). The authors have revisited all the data from this study and we confirm that the reported quantitative data are correct and do not change the results, interpretations, and conclusions of the study. Below is the corrected Figure 5.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Lee, JY., Tuazon, J.P., Corey, S. et al. Correction to: A Gutsy Move for Cell-Based Regenerative Medicine in Parkinson’s Disease: Targeting the Gut Microbiome to Sequester Inflammation and Neurotoxicity. Stem Cell Rev and Rep 18, 2203–2205 (2022). https://doi.org/10.1007/s12015-022-10396-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12015-022-10396-y